<DOC>
	<DOC>NCT02131038</DOC>
	<brief_summary>This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin Allergy Nasal Spray. In addition the effectiveness and safety shall be compared to a Cromoglycid acid containing nasal spray. The patient applies Ectoin Allergy Nasal Spray or Cromoglycid acid containing nasal spray according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and by the patient in a dairy at defined time intervalls.</brief_summary>
	<brief_title>Application of Ectoine Nasal Spray in Comparison With Cromolyn Sodium Containing Nasal Spray in Patients With Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Cromolyn Sodium</mesh_term>
	<criteria>Female or male individuals â‰¥ 18 years Patients with proven Allergic Rhinitis which are treated with Ectoin Nasal Spray or Cromoglycic acid nasal Spray during the observational period Contra indications according to the label</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Ectoine</keyword>
	<keyword>bitop</keyword>
	<keyword>Allergic Rhinitis</keyword>
</DOC>